← All organizations

Foldrx

For profitContributed to NME

Also known as: FoldRx Pharmaceuticals, Inc. | FOLDRX PHARMS

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

Last known activity

Aug 1, 2008

Acquired by Pfizer on Jan 1, 2010

Timeline

2000s

Jan 1, 2003
Foldrx— Founded

2010s

Jan 1, 2010
Pfizer— Acquired By
May 3, 2019
tafamidis— Marketing Organization

Drugs by trial phase (1 distinct, 3 trials)

Phase 3 (1 own, 0 via acquisition)

tafamidis

Indications

Studied for

Marketed drugs (1)

tafamidis

Recent trials (3)

NCT00694161Study directorPhase 2Aug 1, 2008
NCT00791492Study directorPhase 2/Phase 3Jul 1, 2008
NCT00409175Study directorPhase 2/Phase 3Jan 1, 2007

Details

Founded: Cambridge, MA, US Jan 1, 2003
Last known activity: Aug 1, 2008